Pharmacology of autonomic failure;APPROCHE PHARMACOLOGIQUE DES DYSAUTONOMIES

Therapie

Volumn 53, Issue 1, 1998, Pages 35-41

  Senard, J M ^a   Montastruc, J L ^a  

^a INSERM   (France)

Author keywords

Autonomic failure; Clinical pharmacology; Orthostatic hypotension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; DIHYDROERGOCRYPTINE; DOMPERIDONE; DOPAMINE BETA MONOOXYGENASE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROPOIETIN; FLUDROCORTISONE; METOCLOPRAMIDE; THREO 3,4 DIHYDROXYPHENYLSERINE; YOHIMBINE;

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CONFERENCE PAPER; ENZYME DEFICIENCY; HUMAN; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SYMPTOM; SYMPTOMATOLOGY;

EID: 0031939205     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Ensrud KE, Nevitt MC, Yunis C et al. Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. Arch Intern Med 1992; 152: 1058-1064.
2. Rutan GH, Hermanson B, Bild DE et al. Orthostatic hypotension in the older adults. The Cardiovascular Health Study. Hypertension 1992; 19: 508-519.
3. Räihä I, Luutonen S, Piha J et al. Prevalence, predisposing factors, and prognosis importance of postural hypotension. Arch Intern Med 1995; 155: 930-935.
4. Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension. Arch Neurol 1960; 2: 511-527.
5. Bannister R. Introduction and classification. In: Bannister R, Mathias CJ, eds. Autonomic Failure, 3rd edn. Oxford: Oxford University Press, 1992: pp: 1-12.
6. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32: 28-34.
7. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989; 84: 79-100.
8. Murayama S, Arima K, Nakazato Y et al. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2 Oligodendroglial cytoplasmic inclusions. Acta Neuropathol 1992; 84: 32-38.
9. Abe H, Yagishita S, Amano N et al. Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study. Acta Neuropathol 1992; 84: 273-277.
10. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacological distinction of different orthostatic hypotension syndromes. Neurology 1981; 31: 1-7.
11. Bannister R, Crowe R, Eames R, Burnstock G. Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure. Brain 1979; 102: 163-176.
12. Diamond MA, Murray RH, Schmid PG. Idiopathic postural hypotension: Physiologic observations and report of a new mode of therapy. J Clin Invest 1970; 49: 1341-1348.
13. Escourolle R, DE Recondo J, Gray F. Etude anatomopathologique des syndromes parkinsoniens. In: De Ajuriaguerra J, Gauthier G, eds. Monoamines, noyaux gris centraux et syndrome de Parkinson Geneve: George et Cie SA, 1971: 173.
14. Ohama E, Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neurone system. Acta Neuropathol. 1976; 36: 311.
15. Forno LS, Norville RL. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol 1976; 34: 183-197.
16. Gray F. Neuropathologie des syndromes parkinsoniens. Rev Neurol 1988; 144: 229-248.
17. Gibb WRG. Neuropathology in movement disorders. J Neurol Neurosurg Psychiatry 1989 (special suppl): 55-67.
18. Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson's disease. Gastroenterology 1984; 87: 848-856.
19. Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathd 1990; 79: 581-583.
20. Senard JM, Raï S, Lapeyre-Mestre M et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63: 584-589.
21. Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug-induced orthostatic hypotension: a five-year experience in a regional pharmacovigilance center in France. Clin Drug Invest 1997; 14: 61-66.
22. Turkka JT. Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson's disease. Eur Neurol 1987; 26: 203-210.
23. Senard JM, Valet P, Durrieu G et al. Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension. Eur Clin Invest 1990; 20: 613-619.
24. Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1991; 1: 147-155.
25. Bradbury S, Eggelston C. Postural hypotension: A report of three cases. Am Heart J 1925; 1: 73-86.
26. Dotson R, Ochoa J, Marchettini P, Cline M. Sympathetic neural outflow directly recorded in patients with primary autonomic failure: clinical observations, microneurography and histopathology. Neurology 1990; 40: 1079-1085.
27. Goldstein DS, Zimlichman R, Stull R et al. Measurement of regional removal of norepinephrine in man. J Clin Invest 1985; 76: 15-21.
28. Robertson D, Haile V, Perry S et al. Dopamine β-hydroxylase deficiency: A genetic disorder of cardiovascular regulation. Hypertension 1991; 18: 1-8.
29. Thomaides TN, Chaudhuri KR, Maule S et al. Growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet 1992; 340: 263-266.
30. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997; 349: 1877-1881.
31. Galitsky J, Riviere D, Tran Ma et al. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. Eur J Pharmacol 1990; 39: 447-451.
32. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991; 29: R142-R147.
33. Robertson D, Goldberg MR, Tung C et al. Use of alpha adrenoceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Invest 1986; 78: 576-581.
34. Senard JM, Rascol O, Durrieu G et al. Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson's disease or multiple system atrophy. Clin Neuropharmacol 1993; 16: 70-76.
35. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994; 34: 418-423.
36. Senard JM, Rascol O, Rascol A, Montastruc JL. Lack of yohimbine effect on ambulatory blood pressure recording: a double blind cross-over trial in Parkinsonians with orthostatic hypotension. Fundam Clin Pharmacol 1993; 7: 465-470.
37. Nanda RN, Boyle FC, Gillepsie Js et al. Idiopathic orthostatic hypotension from failure of noradrenaline release in a patient with vasomotor innervation. J Neurol Neurosurg Psychiatry 1977; 40: 11-19.
38. Mathias CJ, Matthews WB, Spalding JMK. Postural changes in plasma renin activity and responses to vasoactive drugs in a case of the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1977; 40: 138-143.
39. Bannister R, Boylston AW, Davies B et al. Beta-adrenoceptor numbers and thermodynamics in denervation supersensitivity. J Physol 1981; 319: 369-377.
40. Chobanian AV, Tifft CP, Sackal H, Pitruzella A. Alpha and beta adrenergic receptor activity in circulating blood cells in patients with idiopathic orthostatic hypotension and phaeochromocytoma. Clin Exp Hypertension 1982; 4: 793-806.
41. Robertson D, Hollister AS, Carey E et al. Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction. J Am Coll Cardiol 1984; 3: 850-856.
42. Onrot J, Goldberg MR, Biaggioni I et al. Oral yohimbine in human autonomic failure. Neurology 1987; 37: 215-220.
43. Baser SM, Brown RT, Cuiras M et al. Beta-adrenoceptor sensitivity in autonomic failure. Neurology 1991; 41: 1107-1112.
44. Davies IB, Sudera D, Sever PS. Regulation of adrenoceptors in man during different adrenergic states. In: Kobinger W, Ahlquist RP, eds. Alpha- and beta-adrenoceptors and the cardiovascular system. Princeton, NJ: Excerpta Medica, 1982: 215-244.
45. Kilfeather SA, Gorgoleska G, Davies IB, Turner P. Elevated lymphocyte beta-adrenoceptor density in multiple system atrophy with associated sympathetic degeneration. Br J Clin Pharmacol 1985; 19: 128-129.
46. Zouchos Y, Thomaides T, Pavitt D et al. β-adrenoceptor expression on circulating mononuclear cells of idiopathic Parkinson's disease and autonomic failure patients before and after reduction of central sympathetic outflow by clonidine. Neurology 1993; 43: 1181-1187.
47. Mares A, Davies AO, Taylor AA. Diversity in supercoupling of β2-adrenergic receptors in orthostatic hypotension. Clin Exp Ther 1990; 47: 371-381.
48. Kafta MS, Polinsky RJ, Williams A et al. Alpha-adrenergic receptors in orthostatic hypotension syndromes. Neurology 1984; 34: 1121-1125.
49. Davies IB, Sever PS. Adrenoceptor function in autonomic failure. In: Bannister R ed. Autonomic Failure: a Textbook of Clinical Disorders of the Autonomie Nervous System. Oxford: Oxford Medical Publications, 1988: 348-366.
50. Lacomblez L, Bensimon G, Isnard F et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther 1989; 45: 241-251.
51. Farrow S, Mers A, Banta G et al. Effect of the alpha2-adrenergic antagonist yohimbine on orthostatic tolerance. Hypertension 1990; 15: 877-880.
52. Goldberg MR, Robertson D. Yohimbine: a pharmacological probe for study of the alpha2-adrenoceptor. Pharmacol Rev 1983; 35: 143-180.
53. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996; 10: 225-233.
54. Kuchel O, Buu NT, Gutkowska J, Genest J. Treatment of severe orthostatic hypotension by metoclopramide. Ann Int Med 1980; 93: 841-843.
55. Beretta-Piccoli, C, Weidmann P. Metoclopramide alone or combined with flubiprofene in the treatment of orthostatic hypotension associated with diabetes mellitus. Klin Wochenschr 1982; 60: 863-865.
56. Montastruc JL, Chamontin B, Senard JM, Rascol A. Domperidone in the management of orthostatic hypotension. Clin Neuropharmacol 1985; 8: 91-92.
57. Norbiato G, Bevilacqua M, Righini V et al. Altered vasopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic defect in the hypothalamus. Acta Neurol Scand 1992; 85: 299-303.
58. Kauffman H. Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson's disease. Neurology 1996; 47: 1370-1371.
59. Suzuki T, Sadagoshi H, Sakoda S et al. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxvphenylserine. Neurology 1981; 31: 1323-1326.
60. Muneta S, Iwata T, Hiwada K et al. Effect of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in a patient with spinal cord injury. Jpn Circ J 1992; 56: 243-247.
61. Biaggioni I, Robertson D. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 1987; 2: 1170-1172.
62. Kauffman H, Oribe E, Lyahr MD. Differencial effect of L-threo-3,4. Dihydroxyphenylserine in pure autonomic failure. J Neurol Transm 1991; 3: 143-148.
63. Ushiyama M, Ikeda S, Suzuki T et al. Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment. J Neurol Neurosurg Psychiatry 1996; 61: 99-102.
64. Hoedtke R, Gilmi K, Mattis-Graves K. DL-threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension. Clin Pharmacol Ther 1984; 36: 302-306.
65. Freeman R, Young J, Landsbug L, Lipsitz L. The treatment of postprandial hypotension in autonomic failure with 3,4 dihydroxyphenylserine. Neurology 1996; 47: 1414-1420.
66. Senard JM, Arias A, Berlan M et al. Pharmacological evidence of alphal- and alpha2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury; a case report. Eur J Clin Pharmacol 1991; 41: 593-596.
67. Estan L, Senard JM, Tran Ma et al. Reserpine induces vascular alpha2-adrenergic supersensitivity and platelet alpha2-adrenoceptor up-reguladon in dog. Br J Pharmacol 1990; 101: 329-336.
68. Zacchariah PK, Bloedow DC, Moyer T et al. Pharmacodynamics of midodrine, an antihypotensive agent. Clin Pharmacol Ther 1986; 39: 586-591.
69. Biaggioni I, Zygmunt D, Haile D, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 1990; 65: 89-92.
70. Gordon RD, Ballantine DM, Bachmann AW. Effects of repeated doses of pseudoephedrine on blood pressure and plasma catecholamines in normal subjects and in patients with phaeochromocytoma. Clin Exp Pharm Physiol 1992; 19: 287-290.
71. Jankovic J, Gilden JL, Hiner B et al. Neurogenic orthostatic hypotension: a double blind placebo-controlled study with midodrine. Am J Med 1993; 95: 38-48.
72. Schirger A, Sheps SG, Thomas JE, Fealey RD. Midodrine: a new agent in the treatment of idiopathic orthostatic hypotension and Shy Drager syndrome. Mayo Clin Proc 1981; 56: 429-433.
73. Senard JM, Rascol O, Rascol A, Montastruc JL. Ambulatory blood pressure monitoring in the study of autonomic failure. In: Korczyn AD, ed. Handbook of Autonomic Nervous System Disfunction. New York: Marcel Dekker 1995: 413-425.
74. Deigard A, Hilsted J. No effect of pindolol on postural hypotension in type I (insulin dependent) diabetic patients with autonomic neuropathy. A randomized double-blind controlled study. Diabetologia 1988; 31: 281-284.
75. Leslie PJ, Thompson C, Clarke BF, Ewing DJ. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy. Clin Auton Res 1992; 1: 119-123.
76. Boesen F, Andersen EB, Kanstrup II et al. Treatment of orthostatic hypotension with pindolol. Acta Neurol Scand 1982; 66: 386-391.
77. Ten Harkel ADJ, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Int Med 1992; 232: 139-145.
78. Schwartz GL, Zacchariah PK, Shieps SG, Schirger A. Ambulatory blood pressure monitoring in patients with autonomic failure. Clin Pharmacol Exp 1989; 45: 153.
79. Hoeldtke RD and Streeten DHP. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329: 611-615.
80. Biaggioni I, Robertson D, Krantz S et al. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Int Med 1994; 121: 181-186.